פריוויג'ן

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

IMMUNOGLOBULINS, NORMAL HUMAN

제공처:

CSL BEHRING LTD., ISRAEL

ATC 코드:

J06BA02

약제 형태:

תמיסה לאינפוזיה

구성:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

관리 경로:

תוך-ורידי

처방전 유형:

מרשם נדרש

Manufactured by:

CSL BEHRING AG, SWITZERLAND

치료 그룹:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

치료 영역:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

치료 징후:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

승인 날짜:

2016-06-30